20 results
8-K
EX-99.1
NKTX
Nkarta Inc
25 Mar 24
Regulation FD Disclosure
6:05am
in NHL NKX019 engineering allows cytokine independence, for both persistence and response, further enabling disease-tailored LD NK cells with membrane
PRE 14A
565x1xjxxn
14 Apr 23
Preliminary proxy
5:00pm
DEF 14A
cnrreanv krpt
22 Apr 21
Definitive proxy
12:35pm
10-K
q7hqgve5g417u 0s
25 Mar 21
Annual report
12:00am
8-K
EX-3.2
ft3ibmweh qjo72ybb3
14 Jul 20
Amendments to Articles of Incorporation or Bylaws
4:10pm
424B4
2ad kamouz
10 Jul 20
Prospectus supplement with pricing info
9:35pm
S-1/A
EX-3.4
o2e8f78tjc
2 Jul 20
IPO registration (amended)
5:17pm
S-1/A
9dgqr7j 0l
2 Jul 20
IPO registration (amended)
5:17pm
S-1
bv0gvx2bn2rkn
19 Jun 20
IPO registration
3:24pm
DRS/A
poecrssh20qm9a4k40d
19 May 20
Draft registration statement (amended)
12:00am
DRS/A
y7hx0xx0
20 Apr 20
Draft registration statement (amended)
12:00am
DRS
piulv
28 Feb 20
Draft registration statement
12:00am
- Prev
- 1
- Next